Clinical Trials Browser

Phase 2 × Completed × midostaurin × Clear all

NCT03280030 2025-03-20

A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML

Phase 2 Completed

67 enrolled 21 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01883362 2021-03-17

RADIUS

Phase 2 Completed

60 enrolled 17 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01830361 2020-08-06

MIDOKIT

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01477606 2020-06-04

Protocol in Acute Myeloid Leukemia With FLT3-ITD

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00782067 2018-11-15

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Phase 2 Completed

116 enrolled 16 charts

LymphoidMyeloidOther hematologic neoplasm

Aggression, Leukemia, Leukemia, Mast-Cell, Mastocytosis, Systemic